• OPEN AN ACCOUNT
Indian Indices
Sensex
76,238.86 -705.42
( -0.92%)
Global Indices
Nasdaq
52,794.59 -412.31
(-0.77%)
Dow Jones
7,653.60 -53.54
(-0.69%)
Hang Seng
66,431.13 119.20
(0.18%)
Nikkei 225
10,792.77 -31.49
(-0.29%)
Forex
USD-INR
95.24 -0.24
(-0.25%)
EUR-INR
110.49 -0.08
(-0.07%)
GBP-INR
128.99 -0.20
(-0.15%)
JPY-INR
0.60 0.00
(-0.03%)

EQUITY - MARKET SCREENER

Karnavati Finance Ltd
Industry :  Finance & Investments
BSE Code
ISIN Demat
Book Value()
538928
INE554R01020
0.4308458
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
19.43
13.67
EPS(TTM)
Face Value()
Div & Yield %
0.07
1
0
 

modern engineering & projects limited
Venmax Drugs & Pharmaceuticals standalone net profit declines 85.90% in the March 2026 quarter
May 15,2026
Net profit of Venmax Drugs & Pharmaceuticals declined 85.90% to Rs 0.11 crore in the quarter ended March 2026 as against Rs 0.78 crore during the previous quarter ended March 2025. Sales rose 1093.94% to Rs 3.94 crore in the quarter ended March 2026 as against Rs 0.33 crore during the previous quarter ended March 2025.

For the full year,net profit reported to Rs 0.25 crore in the year ended March 2026 as against net loss of Rs 0.01 crore during the previous year ended March 2025. Sales rose 890.12% to Rs 8.02 crore in the year ended March 2026 as against Rs 0.81 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales3.940.33 1094 8.020.81 890
OPM %0.51-72.73 -1.50-129.63 -
PBDT0.110.78 -86 0.280 0
PBT0.110.78 -86 0.28-0.01 LP
NP0.110.78 -86 0.25-0.01 LP